TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
CADL

Candel Therapeutics Inc

Healthcare · Biotechnology

10.90$ -4.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement CADL
Line item 2019 2020 2021 2022 2023 2024 2025
+0.0% +0.0% +0.0% -75.2% -100.0%
+325.4% +2,329.6% -95.9% -14.6%
+0.0% +0.0% +0.0% -19,284.0%
+32.5% +73.4% +37.0% +17.9% -21.2% +57.9%
+102.8% +106.0% +31.7% -1.2% +1.2% +26.4%
+52.1% +85.5% +34.6% +10.3% -13.1% +44.6%
-89.6% -52.3% +3,122.6% +51.9% -19.5% +1.4%
+131.4% -253.2%

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?